Cleveland Clinic Abu Dhabi, a part of the M42 Group, is set to host two significant global medical summits focusing on complex oncology care and advancements in April.
The Cleveland Clinic Global Innovation Summit in Oncology Care and the New Frontiers Summit in Advanced Hepatobiliary Tumors and Transplantation Oncology will convene over 50 experts in oncology and gastroenterology from the Cleveland Clinic’s global network. These summits underscore the hospital’s pivotal role in medical education and innovation.
Accredited by the American Accreditation Council for Continuing Medical Education, Cleveland Clinic Abu Dhabi stands at the forefront of efforts to enhance healthcare in the UAE and Gulf Cooperation Council countries. The hospital is renowned for its multidisciplinary expertise, attracting top-tier medical education providers, researchers, and clinical experts from around the world.
The Cleveland Clinic Global Summit for Innovation in Oncology Care, slated for April 19-21 at the Four Seasons Hotel Abu Dhabi, will be led by Dr. Faiq Al Jamali, a Consultant General Surgeon at Cleveland Clinic Abu Dhabi’s Digestive Diseases Institute. This summit, accredited by the European Accreditation Council for Continuing Medical Education, will cover various topics including cancer screening, prevention, and advancements in surgical and radiation oncology.
The New Horizons Summit in Advanced Hepatobiliary Tumors and Transplantation Oncology, accredited by the Accreditation Council for Continuing Medical Education, will be held on April 27-28 at Cleveland Clinic Abu Dhabi, under the leadership of Dr. Cristiano Quintini, Head of the Digestive Diseases Institute. This event will attract experts in organ transplantation, liver and bile duct diseases, and oncology, focusing on therapeutic procedures and innovative advancements in the field.
Additionally, the summit will launch the annual Surgical Education Week for Residents, providing resident doctors across the Emirates with practical skills and guidance from distinguished surgeons, alongside career planning and life support lessons.
Dr. Sawsan Abdel Razek, CEO of the Academic Office at Cleveland Clinic Abu Dhabi, emphasized the hospital’s commitment to hosting leading global events for continuing medical education, aligning with its mission to advance global cooperation and medical progress.
Dr. Stephen Grubmeier, Chairman of the Institute of Oncology and Hematology, highlighted the importance of the summits in enriching healthcare practitioners’ knowledge and pushing forward advancements in complex oncology care.
Dr. Cristiano Quintini expressed pride in hosting the New Horizons Summit, emphasizing its focus on exploring advanced technologies and surgical procedures to enhance therapeutic outcomes for patients.
The summits serve as vital platforms for discussing the latest developments in oncology care, from the role of genomics in diagnosis and treatment to insights from world-leading experts. Participants will also have the exclusive opportunity to tour the Fatima Bint Mubarak Center for Oncology, inspired by Cleveland Clinic USA’s Taussig Center for Oncology.
With its experienced team and advanced facilities, Cleveland Clinic Abu Dhabi continues to uphold its commitment to healthcare excellence regionally and globally, providing personalized care for complex cases and advancing treatment options with innovative approaches and technologies.
